Now showing items 1-1 of 1

    • The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort 

      Babayigit C,Kokturk N,Kul S,Cetinkaya PD,Atis Nayci S,Argun Baris S,Karcioglu O,Aysert P,Irmak I,Akbas Yuksel A,Sekibag Y,Baydar Toprak O,Azak E,Mulamahmutoglu S,Cuhadaroglu C,Demirel A,Kerget B,Baran Ketencioglu B,Ozger HS,Ozkan G,Ture Z,Ergan B,Avkan Oguz V,Kilinc O,Ercelik M,Ulukavak Ciftci T,Alici O,Nurlu Temel E,Ataoglu O,Aydin A,Cetiner Bahcetepe D,Gullu YT,Fakili F,Deveci F,Kose N,Tor MM,Gunluoglu G,Altin S,Turgut T,Tuna T,Ozturk O,Dikensoy O,Yildiz Gulhan P,Basyigit I,Boyaci H,Oguzulgen IK,Borekci S,Gemicioglu B,Bayraktar F,Elbek O,Hanta I,Kuzu Okur H,Sagcan G,Uzun O,Akgun M,Altinisik G,Dursun B,Cakir Edis E,Gulhan E,Oner Eyuboglu F,Gultekin O,Havlucu Y,Ozkan M,Sakar Coskun A,Sayiner A,Kalyoncu AF,Itil O,Bayram H (2022)
      Background and objectives: Although several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives of our study ...